Dr. Richard Landrigan, MD

Dr. Landrigan practices at Memorial Medical Center in Las Cruces, New Mexico, part of Lifepoint Health.

Dr. Landrigan's NPI, 1295798619, was assigned on April 7, 2006. Dr. Landrigan graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1975. Dr. Landrigan holds Florida license ME35858.

Dr. Landrigan's primary practice is Memorial Medical Center, at 2450 South Telshor Blvd, Las Cruces, NM 88011 in Dona Ana County. The practice phone is (575) 522-8641.

Dr. Landrigan's primary practice is Memorial Medical Center in Las Cruces, New Mexico, part of Lifepoint Health. Dr. Landrigan is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is New Mexico Cardiovascular Associates. Dmand AI also links Dr. Landrigan to 3 more medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Landrigan practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Landrigan's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Landrigan is board certified in urology by the American Board of Urology. Dmand AI has Dr. Landrigan's licenses on file in 12 states: Florida, Michigan, New Mexico, Idaho, Tennessee, Texas, Georgia, Montana, California, North Carolina, Washington and Louisiana.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate inflammation or infection among the conditions Dr. Landrigan treats.

CMS data shows 508 Medicare services from Dr. Landrigan across 8 procedure codes in 2024, for 120 Medicare patients. Medicare paid $23,770 for them.

CMS counts 120 Medicare patients who saw Dr. Landrigan in 2024. The largest group is 75 to 84, with 51 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Landrigan's median patient age at 71, with 32% women.

In 2024, Dr. Landrigan wrote 576 Medicare Part D claims for 174 patients. 97% of them were for generic drugs. CMS names the drug for 514 of them, across 9 drugs with 11 or more claims each, at $25,143 in total drug cost. In 2023, CMS named 513 claims across 8 drugs.

Dr. Landrigan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Landrigan. Dr. Landrigan has published most often in Urology.

CMS Open Payments shows 12 general payments to Dr. Landrigan from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. United Service Solutions LLC paid the most, $246.

Dr. Landrigan graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1975.

Dr. Landrigan is in network with 20 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.